Mechanism Partial androgen agonist leads to ovarian steroid synthesis inhibition Indications Endometriosis Hereditary angioedema Fibrocystic breast disease Contraindications Pregnancy or breast feeding Genital bleeding Thrombosis or thromboembolic disease Marked hepatic, renal, or cardiac dysfunction Androgen-dependent tumor Toxicity Weight gain Acne Hirsutism/virilization